Regarding: Humar et al. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant 2010;10:1228–1237
Research output: Contribution to journal › Letter › Research › peer-review
| Original language | English |
|---|---|
| Journal | American Journal of Transplantation |
| Volume | 11 |
| Issue number | 2 |
| Pages (from-to) | 408 |
| ISSN | 1600-6135 |
| DOIs | |
| Publication status | Published - 1 Feb 2011 |
- Antiviral Agents, Cytomegalovirus Infections, Ganciclovir, Humans, Kidney Transplantation, Risk Factors, Treatment Outcome
Research areas
ID: 33872552